A liposome having a lipid bilayer, where the lipid bilayer includes either the L or D stereoisomer of an ether lipid or a non-equal mixture of both. Most preferably the liposome also comprises (a) an underivatized phosphatidylcholine; (b) a sterol; (c) about 5-20 mole % of a phosphatidylethanolamine linked to a dicarboxylic acid at the ethanolamine group of the phosphatidylethanolamine, and (d) greater than about 10 mole % to less than about 30 mole % of either the L or D stereoisomer of an ether lipid. The liposome may be used as an anti-cancer or anti-inflammatory agent.

Липосома имея bilayer липида, где bilayer липида вклюает или стереоизомер л или д липида эфира или нон-ravnuh смесь обоих. Most preferably липосома также состоит из (a) underivatized фосфатидилхолин; (b) стерол; (c) о 5-20 моль % phosphatidylethanolamine соединил к двукарбоновой кислоте на группе в составе этаноламина phosphatidylethanolamine, и (d) greater than около 10 моли % к меньш чем около 30 моли % или стереоизомера л или д липида эфира. Липосома может быть использована как anti-cancer или anti-inflammatory вещество.

 
Web www.patentalert.com

< Drug reconstitution and injection device

< Peptides which enhance transport across tissues and methods of identifying and using the same

> Methods of using metaxalone in the treatment of musculoskeletal conditions

> Method for pulmonary and oral delivery of pharmaceuticals

~ 00096